maprotiline has been researched along with Prostatic Neoplasms in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, SS | 1 |
| Chen, WC | 1 |
| Lo, YK | 1 |
| Cheng, JS | 1 |
| Yeh, JH | 1 |
| Cheng, HH | 1 |
| Chen, JS | 1 |
| Chang, HT | 1 |
| Jiann, BP | 1 |
| Huang, JK | 1 |
| Jan, CR | 1 |
1 other study available for maprotiline and Prostatic Neoplasms
| Article | Year |
|---|---|
Effect of the antidepressant maprotiline on Ca2+ movement and proliferation in human prostate cancer cells.
Topics: Antidepressive Agents, Second-Generation; Calcium; Cell Division; Cell Line, Tumor; Cell Survival; F | 2004 |